Skip to content

Attenuation of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation With Single Dose of Dexmedetomidine in Hypertensive Patients.

Attenuation of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation With Single Dose of Dexmedetomidine in Hypertensive Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03204006
Enrollment
70
Registered
2017-06-29
Start date
2018-03-08
Completion date
2020-03-12
Last updated
2020-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Response During Laryngoscopy Intubation

Brief summary

Attenuation of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation With Single Dose of Dexmedetomidine in Hypertensive Patients.

Interventions

DRUGDexmedetomidine

Dexmedetomidine preinduction

DRUGsterile saline

normal saline preinduction

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* \- Age group 20-60 years * ASA grade 1 and 2 * control hypertensive patients.

Exclusion criteria

* \- Consent not given * ASA Grade 3 and 4 * history of myocardial ischemia or infarction, or had an abnormal ECG on admission to the hospital * Patients with cardiovascular, pulmonary, hepatic, and renal disease. * Patients on B blockers. * patients with difficult airway; laryngoscopy and intubation time more than 20 s, or requiring more than two attempts will be exclude from the study.

Design outcomes

Primary

MeasureTime frame
heart ratethrough first 15 min post-induction of anesthesia

Secondary

MeasureTime frame
systolic blood pressurethrough first 15 min post-induction of anesthesia
diastolic blood pressurethrough first 15 min post-induction of anesthesia

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026